131 related articles for article (PubMed ID: 11250097)
1. Nebulisation of rehydrated freeze-dried beclomethasone dipropionate liposomes.
Darwis Y; Kellaway IW
Int J Pharm; 2001 Mar; 215(1-2):113-21. PubMed ID: 11250097
[TBL] [Abstract][Full Text] [Related]
2. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers.
Saari M; Vidgren MT; Koskinen MO; Turjanmaa VM; Nieminen MM
Int J Pharm; 1999 Apr; 181(1):1-9. PubMed ID: 10370197
[TBL] [Abstract][Full Text] [Related]
4. Operating characteristics of 18 different continuous-flow jet nebulizers with beclomethasone dipropionate liposome aerosol.
Waldrep JC; Keyhani K; Black M; Knight V
Chest; 1994 Jan; 105(1):106-10. PubMed ID: 8275719
[TBL] [Abstract][Full Text] [Related]
5. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
Nasr M; Najlah M; D'Emanuele A; Elhissi A
Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive production method of self-cryoprotected nano-liposome powders.
Gala RP; Khan I; Elhissi AM; Alhnan MA
Int J Pharm; 2015; 486(1-2):153-8. PubMed ID: 25796123
[TBL] [Abstract][Full Text] [Related]
7. Fabrication, characterization and optimization of nanostructured lipid carrier formulations using Beclomethasone dipropionate for pulmonary drug delivery via medical nebulizers.
Khan I; Hussein S; Houacine C; Khan Sadozai S; Islam Y; Bnyan R; Elhissi A; Yousaf S
Int J Pharm; 2021 Apr; 598():120376. PubMed ID: 33617949
[TBL] [Abstract][Full Text] [Related]
8. Beclomethasone-loaded lipidic nanocarriers for pulmonary drug delivery: preparation, characterization and in vitro drug release.
Jaafar-Maalej C; Andrieu V; Elaissari A; Fessi H
J Nanosci Nanotechnol; 2011 Mar; 11(3):1841-51. PubMed ID: 21449319
[TBL] [Abstract][Full Text] [Related]
9. Engineering drug ultrafine particles of beclomethasone dipropionate for dry powder inhalation.
Xu LM; Zhang QX; Zhou Y; Zhao H; Wang JX; Chen JF
Int J Pharm; 2012 Oct; 436(1-2):1-9. PubMed ID: 22732674
[TBL] [Abstract][Full Text] [Related]
10. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
[TBL] [Abstract][Full Text] [Related]
11. The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols.
Zeng XM; Pandhal KH; Martin GP
Int J Pharm; 2000 Mar; 197(1-2):41-52. PubMed ID: 10704792
[TBL] [Abstract][Full Text] [Related]
12. Study of the RESS process for producing beclomethasone-17,21-dipropionate particles suitable for pulmonary delivery.
Charpentier PA; Jia M; Lucky RA
AAPS PharmSciTech; 2008; 9(1):39-46. PubMed ID: 18446459
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.
Gillissen A; Richter A; Oster H; Criée CP
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133
[TBL] [Abstract][Full Text] [Related]
14. Limitations of high dose carrier based formulations.
Yeung S; Traini D; Tweedie A; Lewis D; Church T; Young PM
Int J Pharm; 2018 Jun; 544(1):141-152. PubMed ID: 29649519
[TBL] [Abstract][Full Text] [Related]
15. Micronized drug powders in binary mixtures and the effect of physical properties on aerosolization from combination drug dry powder inhalers.
Jetmalani K; Young PM; Smith T; Stewart P; Traini D
Drug Dev Ind Pharm; 2012 Dec; 38(12):1504-11. PubMed ID: 22335558
[TBL] [Abstract][Full Text] [Related]
16. Application of USP inlet extensions to the TSI impactor system 3306/3320 using HFA 227 based solution metered dose inhalers.
Mogalian E; Myrdal PB
Drug Dev Ind Pharm; 2005 Dec; 31(10):977-85. PubMed ID: 16316853
[TBL] [Abstract][Full Text] [Related]
17. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers.
Gupta A; Stein SW; Myrdal PB
J Aerosol Med; 2003; 16(2):167-74. PubMed ID: 12823910
[TBL] [Abstract][Full Text] [Related]
18. Proliposome Powders for the Generation of Liposomes: the Influence of Carbohydrate Carrier and Separation Conditions on Crystallinity and Entrapment of a Model Antiasthma Steroid.
Khan I; Yousaf S; Subramanian S; Alhnan MA; Ahmed W; Elhissi A
AAPS PharmSciTech; 2018 Jan; 19(1):262-274. PubMed ID: 28698930
[TBL] [Abstract][Full Text] [Related]
19. An in-vitro assessment of a NanoCrystal beclomethasone dipropionate colloidal dispersion via ultrasonic nebulization.
Ostrander KD; Bosch HW; Bondanza DM
Eur J Pharm Biopharm; 1999 Nov; 48(3):207-15. PubMed ID: 10612031
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary delivery of beclomethasone liposome aerosol in volunteers. Tolerance and safety.
Waldrep JC; Gilbert BE; Knight CM; Black MB; Scherer PW; Knight V; Eschenbacher W
Chest; 1997 Feb; 111(2):316-23. PubMed ID: 9041975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
